DeFinium Therapeutics Inc (DFTX)
DeFinium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 45,669 | 40,903 | 32,159 | 32,462 | 24,792 |
| Operating Income | -45,669 | -40,903 | -32,159 | -32,462 | -24,792 |
| Interest Expense | 1,274 | 2,338 | 602 | 656 | 727 |
| Other Income | -20,322 | 497 | 9,413 | -1,623 | 11,835 |
| Pre-tax Income | -67,265 | -42,744 | -23,348 | -34,741 | -13,684 |
| Net Income Continuous | -67,265 | -42,744 | -23,348 | -34,741 | -13,684 |
| Net Income | $-67,265 | $-42,744 | $-23,348 | $-34,741 | $-13,684 |
| EPS Basic Total Ops | -0.78 | -0.50 | -0.27 | -0.14 | -0.18 |
| EPS Basic Continuous Ops | -0.78 | -0.50 | -0.27 | -0.15 | -0.18 |
| EPS Diluted Total Ops | -0.78 | -0.50 | -0.35 | 0.13 | -0.27 |
| EPS Diluted Continuous Ops | -0.78 | -0.50 | -0.27 | -0.16 | -0.17 |
| EBITDA(a) | $-45,526 | $-40,903 | $-32,159 | $-31,737 | $-24,792 |